Diseases, Conditions, Syndromes

Common drug colchicine brings hope to COVID fight: Canadian research

A major clinical trial in Canada shows that an inexpensive anti-inflammatory drug called colchicine can significantly reduce the risk of complications and death from COVID-19, bringing "important hope" to sufferers, the lead ...

Diseases, Conditions, Syndromes

Good news: Mild COVID-19 induces lasting antibody protection

Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University ...

Diseases, Conditions, Syndromes

Promising new drug for hepatitis B tested

Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection. Testing ...

Diseases, Conditions, Syndromes

Scientists develop a 10-second HIV test linked to mobile phones

The University of Surrey, working with colleagues at University College London, the Africa Health research Institute (South Africa), OJ-Bio (Newcastle), QV (holdings (Netherlands) and the Japan Radio Co Ltd, have developed ...

Diseases, Conditions, Syndromes

MRI reveals significant brain abnormalities post-COVID

Using a special type of MRI, researchers have uncovered brain changes in patients up to six months after they recovered from COVID-19, according to a study being presented next week at the annual meeting of the Radiological ...

page 100 from 5634